115 related articles for article (PubMed ID: 10556819)
1. A recurrent valpha17/vbeta10 TCR-expressing T cell clone is involved in the pathogenicity of collagen-induced arthritis in DBA/1 mice.
Doncarli A; Chiocchia G; Stasiuk LM; Herbage D; Boutillon MM; Fournier C; Abehsira-Amar O
Eur J Immunol; 1999 Nov; 29(11):3636-42. PubMed ID: 10556819
[TBL] [Abstract][Full Text] [Related]
2. Immunization with TCR Vbeta10 peptide reduces the frequency of type-II collagen-specific Th1 type T cells in BUB/BnJ (H-2q) mice.
Anthony DD; Heeger PS; Haqqi TM
Clin Exp Rheumatol; 2001; 19(4):385-94. PubMed ID: 11491493
[TBL] [Abstract][Full Text] [Related]
3. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis.
Corthay A; Bäcklund J; Broddefalk J; Michaëlsson E; Goldschmidt TJ; Kihlberg J; Holmdahl R
Eur J Immunol; 1998 Aug; 28(8):2580-90. PubMed ID: 9710235
[TBL] [Abstract][Full Text] [Related]
4. Visualization and phenotyping of proinflammatory antigen-specific T cells during collagen-induced arthritis in a mouse with a fixed collagen type II-specific transgenic T-cell receptor β-chain.
Merky P; Batsalova T; Bockermann R; Dzhambazov B; Sehnert B; Burkhardt H; Bäcklund J
Arthritis Res Ther; 2010; 12(4):R155. PubMed ID: 20682070
[TBL] [Abstract][Full Text] [Related]
5. T cell regulation of collagen-induced arthritis in mice. III. Is T cell vaccination a valuable therapy?
Chiocchia G; Manoury-Schwartz B; Boissier MC; Gahery H; Marche PN; Fournier C
Eur J Immunol; 1994 Nov; 24(11):2775-83. PubMed ID: 7525304
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation of established collagen-induced arthritis in mice treated with an anti-T cell receptor antibody.
Maeda T; Saikawa I; Hotokebuchi T; Sugioka Y; Eto M; Murakami Y; Nomoto K
Arthritis Rheum; 1994 Mar; 37(3):406-13. PubMed ID: 8129796
[TBL] [Abstract][Full Text] [Related]
7. Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies.
Hutamekalin P; Saito T; Yamaki K; Mizutani N; Brand DD; Waritani T; Terato K; Yoshino S
J Immunol Methods; 2009 Mar; 343(1):49-55. PubMed ID: 19330909
[TBL] [Abstract][Full Text] [Related]
8. Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies.
Chiocchia G; Boissier MC; Fournier C
Eur J Immunol; 1991 Dec; 21(12):2899-905. PubMed ID: 1836185
[TBL] [Abstract][Full Text] [Related]
9. Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice.
Corthay A; Johansson A; Vestberg M; Holmdahl R
Int Immunol; 1999 Jul; 11(7):1065-73. PubMed ID: 10383939
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific expansion of TCR Vbeta3+ CD4+ T cells in the early stage of collagen-induced arthritis and its arthritogenic role in DBA/1J mice.
Lee JS; Cho ML; Jhun JY; Min SY; Ju JH; Yoon CH; Min JK; Park SH; Kim HY; Cho YG
J Clin Immunol; 2006 May; 26(3):204-12. PubMed ID: 16783460
[TBL] [Abstract][Full Text] [Related]
11. Induction of transient arthritis by the adoptive transfer of a collagen II specific Th1 clone to HLA-DR4 (B1*0401) transgenic mice.
Wang D; Hill JA; Jevnikar AM; Cairns E; Bell DA
J Autoimmun; 2002; 19(1-2):37-43. PubMed ID: 12367557
[TBL] [Abstract][Full Text] [Related]
12. Expression of a type II collagen-specific TCR transgene accelerates the onset of arthritis in mice.
Osman GE; Cheunsuk S; Allen SE; Chi E; Liggitt HD; Hood LE; Ladiges WC
Int Immunol; 1998 Nov; 10(11):1613-22. PubMed ID: 9846690
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints.
Latham KA; Whittington KB; Zhou R; Qian Z; Rosloniec EF
J Immunol; 2005 Apr; 174(7):3978-85. PubMed ID: 15778354
[TBL] [Abstract][Full Text] [Related]
14. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope.
Staines NA; Harper N; Ward FJ; Malmström V; Holmdahl R; Bansal S
Clin Exp Immunol; 1996 Mar; 103(3):368-75. PubMed ID: 8608633
[TBL] [Abstract][Full Text] [Related]
15. Intranasal administration of denatured type II collagen and its fragments can delay the onset of collagen-induced arthritis.
Matsumoto T; Ametani A; Hachimura S; Iwaya A; Taguchi Y; Fujita K; Shigehisa T; Kaminogawa S
Clin Immunol Immunopathol; 1998 Jul; 88(1):70-9. PubMed ID: 9683552
[TBL] [Abstract][Full Text] [Related]
16. T cell regulation of collagen-induced arthritis in mice. II. Immunomodulation of arthritis by cytotoxic T cell hybridomas specific for type II collagen.
Chiocchia G; Boissier MC; Manoury B; Fournier C
Eur J Immunol; 1993 Feb; 23(2):327-32. PubMed ID: 8436167
[TBL] [Abstract][Full Text] [Related]
17. Expression of a transgenic T cell receptor beta chain enhances collagen-induced arthritis.
Mori L; Loetscher H; Kakimoto K; Bluethmann H; Steinmetz M
J Exp Med; 1992 Aug; 176(2):381-8. PubMed ID: 1386871
[TBL] [Abstract][Full Text] [Related]
18. Analysis of type II collagen reactive T cells in the mouse. II. Different localization of immunodominant T cell epitopes on heterologous and autologous type II collagen.
Andersson M; Cremer MA; Terato K; Burkhardt H; Holmdahl R
Scand J Immunol; 1991 May; 33(5):505-10. PubMed ID: 1709517
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.
Honda A; Ametani A; Matsumoto T; Iwaya A; Kano H; Hachimura S; Ohkawa K; Kaminogawa S; Suzuki K; Sercarz EE; Kumar V
Int Immunol; 2004 May; 16(5):737-45. PubMed ID: 15096482
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice.
Kadowaki KM; Matsuno H; Tsuji H; Tunru I
Clin Exp Immunol; 1994 Aug; 97(2):212-8. PubMed ID: 7914155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
